Migdal Insurance & Financial Holdings’s Kite Pharma, Inc. KITE Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-146,791	Closed	-$15.2M	–	598
2017 Q2	$15.2M	Sell	146,791 -81,709	-36%	-$6.67M	0.35%	64
2017 Q1	$17.9M	Buy	228,500 +28,389	+14%	+$1.76M	0.43%	60
2016 Q4	$8.97M	Buy	200,111 +111	+0.1%	+$5.45K	0.23%	73
2016 Q3	$11.2M	Hold	200,000	–	–	0.32%	55
2016 Q2	$10M	Hold	200,000	–	–	0.28%	61
2016 Q1	$9.18M	Buy	200,000 +100,000	+100%	+$4.84M	0.28%	56
2015 Q4	$6.16M	Buy	+100,000	New	+$7.04M	0.18%	67

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings's KITE Position: Q3 2017 in Review

Migdal Insurance & Financial Holdings sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 146,791 shares — an estimated $15.2M sold.

Migdal Insurance & Financial Holdings first reported a position in KITE in Q4 2015 and held it in 7 quarters. The position peaked at $17.9M in Q1 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Migdal Insurance & Financial Holdings reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 146,791 Kite Pharma, Inc. shares in Q3 2017, an estimated $15.2M.
Migdal Insurance & Financial Holdings first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 7 quarters.
Migdal Insurance & Financial Holdings's Kite Pharma, Inc. position peaked at $17.9M in Q1 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2017, filed 6 Nov 2017.